RBC Bioscience Corporation (TPEX:6848)
Taiwan · Delayed Price · Currency is TWD 21.40
+0.10 (0.47%)
Oct 8, 2026, 11:53 AM CST
RBC Bioscience Market Cap
RBC Bioscience has a market cap or net worth of 305.46 million as of October 9, 2026. It is the 41,920th most valuable company in the world and the 2,325th biggest in Taiwan. Its market cap has increased by 18.23% in one year.
Market Cap
305.46M
Enterprise Value
651.12M
Revenue
220.60M
Global Rank
Country Rank
#2,325 Taiwan
PE Ratio
14.55
ChartMarket Cap Chart
Since October 25, 2021, RBC Bioscience's market cap has decreased from 632.27M to 305.46M, a decrease of -51.69%. That is a compound annual growth rate of -13.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 305.46M | 27.00% |
| Dec 31, 2025 | 240.51M | -2.96% |
| Dec 31, 2024 | 247.83M | 17.90% |
| Dec 29, 2023 | 210.20M | 2.21% |
| Dec 30, 2022 | 205.66M | -55.24% |
| Dec 30, 2021 | 459.45M | -27.33% |
| Oct 25, 2021 | 632.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 774.68M |
| MegaPro Biomedical | 773.43M |
| BioLASCO Taiwan | 729.94M |
| Taiwan Advance Bio-Pharmaceutical | 704.70M |
| Neith | 703.95M |
| SynCore Biotechnology Co.,Ltd | 615.39M |
| TaiwanJ Pharmaceuticals | 560.05M |
| LAUNXP Biomedical | 520.90M |